Drugs / Paracetamol-ratiopharm®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04903509 Background | Jun 2021 → Aug 2022 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Paracetamol-ratiopharm | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04903509 ↗ |